Clinical Library
The evidence base
behind cranial remolding therapy.
A curated collection of peer-reviewed research on positional skull deformity - prevalence, diagnosis, and clinical management. Selected to inform clinical practice and support evidence-based decision making.
46.6%
incidence in infants aged 7–12 weeks
25%
prevalence across children 0–18 years
40%
rise in cases since "Back to Sleep", 1992
12%
of adolescents still show signs of positional skull deformity
Articles are provided for clinical reference. All rights remain with the original publishers.
Research Library
Articles
Prevalence
Prevalence and severity of positional plagiocephaly in children and adolescents
Di Rocco et al. · Acta Neurochirurgica · 2019
The first study to measure PPP prevalence across the full pediatric age range. Findings challenge the assumption that skull deformity self-corrects within two years.
25%
overall prevalence across ages 0–18
Relevance to Crownio
The persistence of PPP beyond infancy underscores the need for a device that can initiate treatment in a single visit, without delays from external fabrication.
Management
Management of Positional Plagiocephaly in Children
The ISPN Guide to Pediatric Neurosurgery · ISPN · 2024
The authoritative clinical management guide from ISPN, codifying the current standard of care and the workflow burden Crownio is designed to reduce.
1st
Line treatment: repositioning for infants under 4 months
Relevance to Crownio
The 1-2 week follow-up requirement for standard helmets is precisely the workflow Crownio eliminates - reducing the standard 10–15 visits to approximately 3-4.
Prevalence
The Incidence of Positional Plagiocephaly: A Cohort Study
Mawji et al. · Pediatrics · 2013
The first population-based incidence study using 4 community data sites - the most statistically robust prevalence measure available.
46.6%
incidence in infants aged 7–12 weeks
Relevance to Crownio
Nearly half of all infants show signs of plagiocephaly by 7-12 weeks, making same-day fitting capability clinically critical.
Diagnosis
Deformational Plagiocephaly, Brachycephaly & Scaphocephaly - Part I: Terminology, Diagnosis & Etiopathogenesis
Rogers · J. Craniofacial Surgery · 2011
The most widely-cited comprehensive clinical review on cranial deformation, establishing the terminology and diagnostic framework used across the field.
19.7%
Combined prevalence of cranial flattening at peak in healthy infants
Relevance to Crownio
The three conditions Rogers defines are exactly the three indications Crownio is engineered to treat.
Treatment
Deformational Plagiocephaly, Brachycephaly & Scaphocephaly - Part II: Prevention and Treatment
Rogers · J. Craniofacial Surgery · 2011
The companion review covering the full evidence base for cranial orthosis therapy - establishing that age at initiation is a significant predictor of outcome.
Early
intervention shown to improve outcomes
Relevance to Crownio
Every week saved in production and fitting time is a week closer to the optimal intervention window.
Clinical Library
The evidence base
behind cranial remolding therapy.
A curated collection of peer-reviewed research on positional skull deformity - prevalence, diagnosis, and clinical management. Selected to inform clinical practice and support evidence-based decision making.
46.6%
incidence in infants
aged 7–12 weeks
25%
prevalence across
children 0–18 years
40%
rise in cases since
"Back to Sleep", 1992
12%
of adolescents still show signs
of positional skull deformity
Articles are provided for clinical reference. All rights remain with the original publishers.
Research Library
Articles
Prevalence
46.6%
The Incidence of Positional Plagiocephaly: A Cohort Study
incidence in infants
aged 7–12 weeks
Mawji et al. · Pediatrics · 2013
First population-based incidence study across 4 community sites. Found 46.6% incidence in infants aged 7–12 weeks — the single strongest prevalence statistic in the literature, underscoring the scale of the clinical need.
Management
1-2
Management of Positional Plagiocephaly in Children
week check-up
intervals (standard)
The ISPN Guide to Pediatric Neurosurgery · ISPN · 2024
Authoritative clinical management guide covering repositioning, physical therapy, and helmet therapy. Recommends cranial orthosis for moderate-to-severe persistent cases, with 1–2 week check-up intervals — the standard workflow Crownio streamlines.
Prevalence
25%
Prevalence and severity of positional plagiocephaly in children and adolescents
overall prevalence
across ages 0–18
Di Rocco et al. · Acta Neurochirurgica · 2019
First study to measure PPP prevalence across all ages 0–18. Found 25% overall prevalence and significant persistence into adolescence (12% at ages 13–18), challenging the assumption that skull deformity self-corrects by age 2.
Treatment
Early
Deformational Plagiocephaly, Brachycephaly & Scaphocephaly — Part II: Prevention and Treatment
intervention shown to improve outcomes
Rogers · Journal of Craniofacial Surgery · 2011
The companion review covering prevention strategies, conservative treatment, and cranial orthosis therapy. Establishes the clinical rationale for early intervention and the importance of minimising delay to optimal treatment window.
Diagnosis
3
Deformational Plagiocephaly, Brachycephaly & Scaphocephaly — Part I: Terminology, Diagnosis & Etiopathogenesis
conditions covered
in depth
Rogers · Journal of Craniofacial Surgery · 2011
Comprehensive clinical review from Harvard / Children's Hospital Boston defining and distinguishing deformational plagiocephaly, brachycephaly, and scaphocephaly - the three primary conditions Crownio is designed to treat.
PREVALENCE
Prevalence and severity of positional plagiocephaly in children and adolescents
Authors
Journal
Year
Type
Focus
Di Rocco et al.
Acta Neurochirurgica
2019
Original Research
Prevalence · Natural history
25%
overall prevalence of PPP
across ages 0–18
Articles
The first study to systematically measure PPP prevalence across the full pediatric age range, from infants to adolescents. The findings challenge the widely held clinical assumption that skull deformity self-corrects within the first two years of life.
Key findings
40.5%
Prevalence in infants under 1 year. Consistent with prior literature
25%
Overall prevalence across all 165 children studied (ages 0–18)
12%
Persistence into adolescence (ages 13–18) - higher than previously reported
79%
Of plagiocephaly cases occurred in male patients
Relevance to Crownio
The persistence of PPP beyond infancy underscores the importance of early clinical intervention, and the need for a device that can initiate treatment in a single visit, without delays from external fabrication.
Why this research matters
MANAGEMENT
Management of Positional Plagiocephaly in Children
Authors
Journal
Year
Type
Focus
ISPN Guideline Group
ISPN Pediatric Guide
August 2024
Clinical Guidelines
Treatment · Management
1-2
week check-up intervals
under standard helmet protocol
Articles
The authoritative clinical management guide for positional plagiocephaly from the International Society for Pediatric Neurosurgery. It codifies the current standard of care and makes explicit the workflow burden that Crownio is designed to reduce.
Key findings
1st
Line treatment: repositioning for infants under 4 months
Mod–
Severe persistent cases: helmet therapy recommended by CNS guidelines
1-2
Week orthotist check-up intervals required under standard helmet protocol
Early
Initiation of therapy strongly associated with better outcomes
Relevance to Crownio
The 1-2 week follow-up requirement for standard helmets is precisely the workflow Crownio eliminates. By enabling real-time in-clinic adjustment, it reduces the standard 10–15 visits to approximately 3–4. A 75% reduction.
Why this research matters
PREVALENCE
The Incidence of Positional Plagiocephaly: A Cohort Study
Authors
Journal
Year
Type
Focus
Mawji et al.
Pediatrics
2013
Prospective Cohort Study
Incidence · Epidemiology
46.6%
incidence in infants
aged 7–12 weeks
Articles
The first population-based incidence study using 4 community data collection sites, making it the most statistically robust measure of plagiocephaly incidence available. The 46.6% figure is the single most-cited prevalence statistic in the field.
Key findings
440
Healthy full-term infants assessed across 4 community health centres in Calgary
46.6%
Incidence at 7–12 weeks. The highest and most robust population-level estimate
78.3%
Of affected infants had a mild form of plagiocephaly at presentation
63.2%
Of cases presented on the right side, consistent with birth canal positioning
Relevance to Crownio
Nearly half of all infants show signs of plagiocephaly by 7–12 weeks. This scale of incidence, combined with the optimal intervention window of 3–6 months, makes same-day fitting capability - Crownio's core differentiator - clinically critical.
Why this research matters
DIAGNOSIS
Deformational Plagiocephaly, Brachycephaly & Scaphocephaly - Part I: Terminology, Diagnosis & Etiopathogenesis
Authors
Journal
Year
Type
Focus
Gary F. Rogers MD
J. Craniofacial Surgery
2011
Clinical Review
Diagnosis · Classification
Part 1
of 2 - Terminology,
Diagnosis & Causes
Articles
The most widely-cited comprehensive clinical review on cranial deformation from Harvard / Children's Hospital Boston. Part I establishes the terminology and diagnostic framework used across the field, and cited directly in Crownio's patent.
Key findings
3
Distinct conditions clearly defined: plagiocephaly, brachycephaly, scaphocephaly
19.7%
Combined prevalence of cranial flattening at peak (age 4 months) in healthy infants
40%
Reduction in SIDS following Back to Sleep (1992), with a corresponding rise in PPP
CMT
Congenital muscular torticollis identified as a primary driver of plagiocephaly
Relevance to Crownio
The three conditions Rogers defines - plagiocephaly, brachycephaly, and scaphocephaly - are exactly the three indications Crownio is engineered to treat. This review provides the clinical classification framework that underpins Crownio's design.
Why this research matters
TREATMENT
Deformational Plagiocephaly, Brachycephaly & Scaphocephaly - Part II: Prevention and Treatment
Authors
Journal
Year
Type
Focus
Gary F. Rogers MD
J. Craniofacial Surgery
2011
Clinical Review
Treatment · Prevention
Part 2
of 2 - Prevention
& Treatment
Articles
The companion review to Part I, covering the full evidence base for cranial orthosis therapy. Establishes that age at initiation of treatment is a significant predictor of outcome, and that delays to the optimal developmental window directly reduce effectiveness.
Key findings
↓Age
Significant negative association between age at therapy initiation and improvement
3-6
Months identified as the optimal treatment window for cranial orthosis therapy
Rare
Surgical intervention - orthotic devices resolve the vast majority of cases
CMT
torticollis treatment essential. Must be addressed alongside cranial orthosis
Relevance to Crownio
The finding that delay past the optimal window reduces treatment effectiveness directly supports Crownio's same-day fitting model. Every week saved in production and fitting time is a week closer to the optimal intervention window.
Why this research matters
A modern, scalable approach to cranial care built for clinicians, healthcare systems, and the families they serve.
Crownio is not yet available for sale in the United States.
© 2026 Occipo Ltd. All rights reserved
Crownio™ is a trademark of Occipo Ltd.